Noriko Yanagitani

机构：The Cancer Institute Hospital, Japanese Foundation For Cancer Research

发表论文 281 篇 · 总被引 7945 次 · h-index 45

代表论文

• Osimertinib with or without Chemotherapy in EGFR -Mutated Advanced NSCLC (2023 · New England Journal of Medicine · 被引 732)
• Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study (2024 · Journal of Clinical Oncology · 被引 132)
• Survival with Osimertinib plus Chemotherapy in EGFR -Mutated Advanced NSCLC (2025 · New England Journal of Medicine · 被引 106)
• Neoadjuvant Osimertinib for Resectable EGFR -Mutated Non–Small Cell Lung Cancer (2025 · Journal of Clinical Oncology · 被引 89)
• Atezolizumab and Platinum Plus Pemetrexed With or Without Bevacizumab for Metastatic Nonsquamous Non–Small Cell Lung Cancer (2023 · JAMA Oncology · 被引 54)
• Abstract CT017: FLAURA2: exploratory analysis of baseline (BL) and on-treatment plasma EGFRm dynamics in patients (pts) with EGFRm advanced NSCLC treated with first-line (1L) osimertinib (osi) ± platinum-pemetrexed (2024 · Cancer Research · 被引 27)